Dr. Steven Jones, PhD, FRSC, FCAHS
Head of Bioinformatics and Co-Director, Canada's Michael Smith Genome Sciences Centre, BC Cancer
| Phone | 604-877-6083 |
|---|---|
| Fax | 604-876-3561 |
| sjones@bcgsc.ca |
Affiliations
Canada Research Chair in Computational Genomics, University of British Columbia
Professor, Medical Genetics, University of British Columbia
Director Bioinformatics, Genome BC Bioinformatics Platform, Genome BC
Founding Director, CIHR/MSFHR Bioinformatics Training Program
Director, Bioinformatics Graduate Program, University of British Columbia
Professor, Genetics Graduate Program, University of British Columbia
Associate Member, Peter Wall Institute for Advanced Studies
Associate Member, Michael Smith Laboratories, University of British Columbia
Professional Profile
In 2005, Dr. Jones was identified as one of Canada's top 40 professionals under 40 by Caldwell Partners International as well as by Business in Vancouver. He has also received the Spencer Award for IT innovation and the 2007 Medical Genetics teaching award from UBC. He is a founding director of the CIHR/MSFHR Bioinformatics Training Program as well as director of UBC’s Bioinformatics Graduate Program. In 2011, he was inducted as a Fellow of the Royal Society of Canada for contributions to Genomics and Bioinformatics. In 2012, he was a recipient of the prestigious UBC Killam teaching prize in recognition of his contributions to graduate bioinformatic education. In May of 2014, he was awarded the Distinguished Achievement Award by the Faculty of Medicine at UBC. In June 2014, Dr. Jones became a Fellow of the Canadian Academy of Health Sciences. In 2019, he became the first Canada Research Chair in Computational Genomics.
Dr. Jones' complete CV is available here.
Research Projects
Cancer bioinformatics and genomics
Dr. Jones' team uses bioinformatics to investigate the landscape of mutations present in cancer genomes and the early genomic events that give rise to and promote the progression of cancer. To achieve these goals, his laboratory analyzes Next Generation Sequencing data and develops novel computational approaches and methodologies. A significant aim of Dr. Jones’ research program is to find innovative ways to exploit specific genomic profiles within an individual cancer for therapeutic purposes. For example, his team has identified a number of epigenetic modifications that may potentially be targeted to reverse the effects of cancer initiating mutations. His lab is using computational approaches, such as molecular docking and molecular dynamics, to identify and refine compounds that can modify the cancer epigenome.
More information about the Jones lab is available here.